References
Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.
Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, Richardson-Harman N, et al. RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate. AIDS Res Hum Retroviruses. 2012;28(11):1412–21.
CONRAD. Safety and effectiveness of tenofovir gel in the prevention of Human Immunodeficiency Virus (HIV-1) infection in young women and the effects of tenofovir gel on the incidence of Herpes Simplex Virus (HSV-2) infection. 2011. http://clinicaltrials.gov/ct2/show/NCT01386294.
Herrera C, Shattock RJ. Potential use of protease inhibitors as vaginal and colorectal microbicides. Curr HIV Res. 2012;10(1):42–52.
Herrera C, Shattock RJ. Candidate microbicides and their mechanisms of action. Curr Top Microbiol Immunol. 2014;383:1–25.
Hillier SL, Moench T, Shattock R, Black R, Reichelderfer P, Veronese F. In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr. 2005;39(1):1–8.
Keele BF. Identifying and characterizing recently transmitted viruses. Curr Opin HIV AIDS. 2010;5(4):327–34.
Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009;458(7241):1034–8.
Mehellou Y, De Clercq E. Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go? J Med Chem. 2010;53(2):521–38.
MTN. MTN statement on decision to discontinue use of tenofovir gel in VOICE, a major HIV prevention study in women. 2011. http://www.mtnstopshiv.org/node/3909.
NIAID. Safety and effectiveness of tenofovir 1 % gel, tenofovir disoproxil fumarate, and emtricitabine/tenofovir disoproxil fumarate tablets in preventing HIV in women. 2011. http://clinicaltrials.gov/ct2/show/NCT00705679.
Ramjee G, Kamali A, McCormack S. The last decade of microbicide clinical trials in Africa: from hypothesis to facts. AIDS. 2010;24:S40–9.
Shattock RJ, Rosenberg Z. Microbicides: topical prevention against HIV. Cold Spring Harb Perspect Med. 2012;2(2):a007385.
Shattock RJ, Warren M, McCormack S, Hankins CA. AIDS. Turning the tide against HIV. Science. 2011;333(6038):42–3.
Zhao B, Mankowski MK, Snyder BA, Ptak RG, Liwang PJ. Highly potent chimeric inhibitors targeting two steps of HIV cell entry. J Biol Chem. 2011;286(32):28370–81.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Herrera, C., Shattock, R. (2014). HIV-1 Transmission Blocking Microbicides. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_144-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9610-6_144-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-9610-6
eBook Packages: Springer Reference MedicineReference Module Medicine